Budesonide EP Impurity H
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

313474-58-7Budesonide EP Impurity H

● In Stock

Catalogue No.:VL34010
CAS No.:313474-58-7
Mol. Formula:C25H32O5
Mol. Weight:412.52 g/mol

Additional information on CAS 313474-58-7

Parent drug

Budesonide

IUPAC Name

16α,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione

Synonyms

N/A

Description

Budesonide EP Impurity H (CAS 313474-58-7) is a defined corticosteroid-related process and/or degradation impurity associated with the budesonide scaffold, with molecular formula C25H32O5 and molecular weight 412.52 g/mol. Its structural relationship to the parent glucocorticoid suggests origin from site-selective oxidation, acetal rearrangement, or synthetic intermediate carryover during esterification and deprotection steps. Because trace-level chromatographic resolution is often required, characterization commonly relies on LC-MS/MS, high-resolution LC-MS, and orthogonal HPLC with UV detection; NMR may be needed for structure assignment. In regulatory contexts, such impurities are controlled through pharmacopeial specifications and impurity profiling.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url